Investor Presentaiton
•
•
•
R&D - Preparing for the future
Consistently higher spend in the
years ahead
•
Spend at over 6% planned
India Business
• 180 products added for next 5
years (Last 3 years: 30)
100 NDDS & First time
launches stepped up
International Operations
• 64 New projects (LY 45)
•
New projects in Oncology,
Dermatology, Ophthalmology,
Injectables
Manpower
Increase of 400+ Scientists
Number of Projects for International markets
New Projects ■Total running Projects
74
63
96
49
105
14
45
124
64
174
2011-12
2012-13
2013-14
2014-15
2015-16
Manpower
• Addition of around
400 scientists
Increase in specialty &
complex projects
• Oncology (solid orals)
• Dermatology
• Ophthalmics
• FTFs
• NDDS for Brazil & BG
Markets
.
• Orphan DrugsView entire presentation